pipette
ENEnglish

Env-specific antibodies promote post-treatment control in SIV-infected macaques

Vidisha Singh, Divine Burgess, Jordan N. Goldy, Amir Dashti, Hannah King, Emily J. Fray, Anushka Singhal, Maud Mavigner, Nils Schoof, Zain Siddiqi, Rosemarie D. Mason, Jeffrey T. Safrit, Vinh B. Dinh, Deanna A. Kulpa, Rafick‐Pierre Sékaly, Mirko Paiardini, Jeffrey D. Lifson, Robert F. Siliciano, Janet D'Angelo Siliciano, Mario Roederer, Ashish Sharma, Guido Silvestri, Ann Chahroudi

Revista con revisión por pares

En palabras de los autores

Abstract Viral latency reversal was observed in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving antiretroviral therapy (ART), CD8α lymphocyte depletion and N-803 immunotherapy. However, this therapeutic approach did not reduce the viral reservoir size and treatment interruption resulted in rapid virus rebound. Here, to address this shortfall, we used four anti-SIV Env-specific rhesus IgG1 monoclonal antibodies (RhmAbs) that recognize unique targets on the SIV envelope. SIV mac239 -infected macaques were treated with ART only (group 1); ART + RhmAbs (group 2); or ART + RhmAbs + CD8α-depletion + N-803 (group 3). Robust latency reversal was only achieved in group 3. Viraemia rebounded in all macaques with similar kinetics after treatment interruption. However, compared with pre-ART viral loads, a greater fold reduction in rebound viraemia was seen in groups 2 and 3 and post-treatment control (PTC) required SIV RhmAbs. CD4 + T cells from macaques with PTC maintained low levels of intact SIV proviruses off ART and expressed increased interferon and decreased TGF-β signalling genes. This antiviral gene expression profile was also observed in CD4 + T cells with lower human immunodeficiency virus (HIV)-DNA content from ART-treated people with HIV. These results suggest that reduced virus production may contribute to PTC following ART interruption and provide a target for immune-based strategies to achieve durable viral control.

Resultado principalEl resumen no menciona limitaciones.

Apareció: jueves, 12 de noviembre. Nature Microbiology. Revista con revisión por pares.

DOI: 10.1038/s41564-026-02426-z